• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Activity of beta-lactamases against beta-lactams.

作者信息

Stratton C W

机构信息

Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.

出版信息

J Antimicrob Chemother. 1988 Jul;22 Suppl A:23-35. doi: 10.1093/jac/22.supplement_a.23.

DOI:10.1093/jac/22.supplement_a.23
PMID:3062002
Abstract

Resistance mediated by beta-lactamases is an important mechanism which has evolved in both Gram-positive and Gram-negative bacteria. There are a large number of different beta-lactamases produced by micro-organisms. Synthesis can be mediated by chromosomes, plasmids, or transposons. Enzyme kinetics for these different beta-lactamases are expressed as affinity of the enzyme for the substrate (1/Km) and rate of hydrolysis of the substrate by the enzyme (Vmax). Such kinetics at physiological concentrations of the enzyme and substrate are important factors in determining the activity of beta-lactam agents. Other factors include the cellular location and amount of enzyme. The clinical importance of subtle differences in beta-lactamase-mediated resistance for both Gram-positive and Gram-negative bacteria is becoming apparent. Antagonism of beta-lactams by beta-lactamases becomes increasingly more important as a resistance mechanism as our knowledge and understanding of this phenomenon grows.

摘要

相似文献

1
Activity of beta-lactamases against beta-lactams.
J Antimicrob Chemother. 1988 Jul;22 Suppl A:23-35. doi: 10.1093/jac/22.supplement_a.23.
2
Sch 29482: stability and inhibitory potency towards beta-lactamases from Gram-negative bacteria.
J Antimicrob Chemother. 1982 Feb;9 Suppl C:123-32. doi: 10.1093/jac/9.suppl_c.123.
3
beta-Lactamases of gram-negative bacteria: new challenges for new drugs.革兰氏阴性菌的β-内酰胺酶:新药面临的新挑战。
Clin Infect Dis. 1992 May;14(5):1089-99. doi: 10.1093/clinids/14.5.1089.
4
Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.青霉素结合蛋白与β-内酰胺酶:它们对头孢菌素及其他新型β-内酰胺类药物使用的影响
Curr Clin Top Infect Dis. 1987;8:37-61.
5
Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics.β-内酰胺酶在革兰氏阴性杆菌对β-内酰胺类抗生素耐药性中的作用。
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S482-6. doi: 10.1093/clinids/8.supplement_5.s482.
6
Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics.肠杆菌科细菌对β-内酰胺类抗生素耐药的遗传和生化基础。
J Antimicrob Chemother. 1986 Oct;18 Suppl B:31-8. doi: 10.1093/jac/18.supplement_b.31.
7
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.β-内酰胺酶对细菌耐药性的作用以及抑制β-内酰胺酶的机制。
Am J Med. 1985 Nov 29;79(5B):2-12. doi: 10.1016/0002-9343(85)90123-8.
8
Beta-lactamases and beta-lactamase inhibitors.β-内酰胺酶与β-内酰胺酶抑制剂
Int J Antimicrob Agents. 1999 Aug;12 Suppl 1:S3-7; discussion S26-7. doi: 10.1016/s0924-8579(99)00085-0.
9
Meeting the challenges of beta-lactamases.应对β-内酰胺酶的挑战。
J Antimicrob Chemother. 1993 Jan;31 Suppl A:1-8. doi: 10.1093/jac/31.suppl_a.1.
10
Recent developments in beta-lactamase research and their implications for the future.β-内酰胺酶研究的最新进展及其对未来的影响。
Rev Infect Dis. 1988 Jul-Aug;10(4):681-90. doi: 10.1093/clinids/10.4.681.